ketoconazole has been researched along with Bacterial Vaginitides in 3 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effectiveness of the combination of ketoconazol 400 mg + clindamycin 100 mg for 6 days compared to ketoconazol 800 mg + clindamycin 100 mg in Candida vaginitis and bacterial vaginosis." | 9.11 | [Comparison of efficacy of combination of ketokonazol 400 mg + clindamycin 100 mg with ketokonazol 800 mg + clindamycin 100 mg in the treatment of vaginitis due to Candida and bacterial vaginosis]. ( Garibay, M; Godínez, V; Mirabent, F; Pérez Calderón, A, 2005) |
| "To evaluate the effectiveness of the combination of ketoconazol 400 mg + clindamycin 100 mg for 6 days compared to ketoconazol 800 mg + clindamycin 100 mg in Candida vaginitis and bacterial vaginosis." | 5.11 | [Comparison of efficacy of combination of ketokonazol 400 mg + clindamycin 100 mg with ketokonazol 800 mg + clindamycin 100 mg in the treatment of vaginitis due to Candida and bacterial vaginosis]. ( Garibay, M; Godínez, V; Mirabent, F; Pérez Calderón, A, 2005) |
| " Here we present the results in the relief of vaginitis and vaginosis with two different dosage forms." | 2.76 | [Evaluation of efficacy of ketoconazole 800 mg-clindamycin 100 mg tablets vaginal against ketoconazole 800 mg- clindamycin 100 mg vaginal capsules in candida vaginitis and vaginosis]. ( Bravo-Topete, EG; Cejudo-Alvarez, J; Garibay-Valencia, M; Herrera-Villalobos, JE; Martínez-García, A; Mirabent-González, F, 2011) |
| "Bacterial vaginosis was more common in non-pregnant women (33% vs 23%) whereas C." | 1.29 | Aetiology of vaginal infections in pregnant and non-pregnant women in Barbados. ( Levett, PN, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martínez-García, A | 1 |
| Cejudo-Alvarez, J | 1 |
| Bravo-Topete, EG | 1 |
| Herrera-Villalobos, JE | 1 |
| Garibay-Valencia, M | 1 |
| Mirabent-González, F | 1 |
| Godínez, V | 1 |
| Garibay, M | 1 |
| Mirabent, F | 1 |
| Pérez Calderón, A | 1 |
| Levett, PN | 1 |
2 trials available for ketoconazole and Bacterial Vaginitides
| Article | Year |
|---|---|
[Evaluation of efficacy of ketoconazole 800 mg-clindamycin 100 mg tablets vaginal against ketoconazole 800 mg- clindamycin 100 mg vaginal capsules in candida vaginitis and vaginosis].
Topics: Actinomycetales Infections; Administration, Intravaginal; Adolescent; Adult; Candida albicans; Candi | 2011 |
[Comparison of efficacy of combination of ketokonazol 400 mg + clindamycin 100 mg with ketokonazol 800 mg + clindamycin 100 mg in the treatment of vaginitis due to Candida and bacterial vaginosis].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Clindamycin; Double-Blind | 2005 |
1 other study available for ketoconazole and Bacterial Vaginitides
| Article | Year |
|---|---|
Aetiology of vaginal infections in pregnant and non-pregnant women in Barbados.
Topics: Adolescent; Adult; Animals; Antifungal Agents; Antitrichomonal Agents; Barbados; Candida albicans; F | 1995 |